← Evidence map

ArticleOncotarget2017

Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer.

Yusuke Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

43 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29069775